Future work targeting GSR KO to only the lung tumor cells, and combining it with inhibition of GSH synthesis will reveal whether inhibition of both GSH synthesis and recycling within the tumor cells abolishes the Nrf2-mediated tumor initiation phenotype. The gene discussed is GSR; the disease is neoplasm.